Page last updated: 2024-08-16

technetium tc 99m sestamibi and Castleman Disease

technetium tc 99m sestamibi has been researched along with Castleman Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gómez Pérez, JR; Perera Pintado, A; Pérez Valdés, M; Rodríguez Pérez, JL; Sánchez Del Campo Romero, M; Sánchez Mendoza, EL; Solano Bravo, ME1
Aktolun, C; Bayhan, H; Celasun, B; Kir, MK1

Other Studies

2 other study(ies) available for technetium tc 99m sestamibi and Castleman Disease

ArticleYear
[Value of scintigraphy with 99mTc-MIBI in the diagnosis and follow-up of Hodgkin's and non-Hodgkin's lymphomas].
    Revista espanola de medicina nuclear, 2000, Volume: 19, Issue:2

    Topics: Adolescent; Adult; Aged; Castleman Disease; Child; Child, Preschool; Evaluation Studies as Topic; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphadenitis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi

2000
Unexpected uptake of technetium 99m hexakis-2-methoxy-isobutylisonitrile in giant lymph node hyperplasia of the mediastinum (Castleman's disease).
    European journal of nuclear medicine, 1991, Volume: 18, Issue:10

    Topics: Adult; Castleman Disease; Humans; Male; Nitriles; Organotechnetium Compounds; Radionuclide Imaging; Technetium Tc 99m Sestamibi

1991